For example, in 2020 the research group led by Fabrício Figueiró demonstrated that glioma-derived extracellular vesicles expressing CD9, HSP70, CD39, and CD73, and producing adenosine, reduced glioma progression by modulating the tumor microenvironment. Here, ENTPD1 is linked to central nervous system cancer.